Based on these results, treatment with Bev (10 mg/kg) + anti-CD47 (20 mg/kg) reduced the tumour volume by 84.64 ± 5.23% (Figure 3B; Supplementary Table S6). The gene discussed is CD47; the disease is neoplasm.